Amedisys — Q3 2021 Earnings Presentation
18 slides from Amedisys's earnings presentation, Nov 2, 2021
Slide 1: Amedisys Third Quarter 2021 Earnings Call Supplemental Slides
Amedisys Third Quarter 2021 Earnings Call Supplemental Slides November 3rd, 2021 Exhibit 99.2
Slide 2: Forward-looking statements
This presentation may include forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations and assumptions about our business that are subject to a variety of risks and uncertainties that could cau
Slide 3: Our Key Areas of Focus
Our Key Areas of Focus Strategic areas of focus and progress made during Q3’21 Home Health*: Total same store admissions +1%, Total same store volume +1% Hospice: Admissions +1% (+5% sequentially), ADC -5% Personal Care: Billable hours / quarter -17%. Personal Care Network drove ~$500K in revenue to
Slide 4: Highlights and Summary Financial Results (Adjusted): 3Q 2021
Highlights and Summary Financial Results (Adjusted): 3Q 2021(1) Home Health total same store volume +1%, total same store admissions +1%; Hospice same store admissions +1%; Margin pressure driven by Hospice ADC decline & labor costs The financial results for the three-month periods ended September 3
Slide 5: Medicare FFS: Reimbursed over a 30-day period of care Private Episodic: MA and Commercial
Medicare FFS: Reimbursed over a 30-day period of care Private Episodic: MA and Commercial plans who reimburse us over a 30-day period of care, majority of which range from 95% - 100% of Medicare rates Per Visit: Managed care, Medicaid and private payors reimbursing us per visit performed Hospice Per
Slide 6: Home Health and Hospice Segment (Adjusted) – 3Q 2021
Home Health and Hospice Segment (Adjusted) – 3Q 2021(1) Revenue per Episode up 2.9% (+1.9% rate increase effective 1/1/2021) Y/Y CPV up $5.98 (+6.2%, primarily due to an increase in contractor utilization, new hire pay and raises) Visits per Episode decreased 0.6 Home Health Highlights Same store ad
Slide 7: General & Administrative Expenses – Adjusted
General & Administrative Expenses – Adjusted (1,2) Notes: Year over year total G&A is relatively flat; total G&A as a percentage of revenue decreased 50 basis points Increases related to the Contessa acquisition, a slowdown in prior year spend related to COVID-19, raises, the addition of resources t
Slide 8: Cost per Visit Components
Components 3Q’20 2Q’21 3Q’21 YoY Variance Detail Initiatives Salaries $64.81 $65.02 $67.58 $2.77 YoY increase due to higher fixed new hire pay due to the timing of hires and planned wage increases (new hire pay = $2.06; raises = $1.00) Sequential increase due to the same drivers, partially offset by
Slide 9: Driving Top Line Growth
Driving Top Line Growth Home Health total volume, Hospice admissions and ADC, as well as Personal Care billable hours lagging due to prolonged COVID-19 impacts related to Delta variant (staffing challenges, increase in clinician quarantine and unexpected increase in hospice discharge rate) Home Heal
Slide 10: Industry Leading Quality Scores
Industry Leading Quality Scores Note: Top Competitor Avg weighted by CCN count and includes LHC, Kindred, AFAM, EHC and BKD Metric OCT 19 Release JAN 20 Release APR 20 Release Oct 20 Release Quality of Patient Care 4.28 4.27 4.26 4.33 Entities at 4+ Stars 88% 86% 86% 92% Metric OCT 19 Release JAN 20
Slide 11: Hospice Quality
Hospice Quality: Amedisys Hospice Continues to Move Towards Best-in-Class Hospice Quality Hospice Compare HIS and CAHPS reporting currently “frozen” and will resume reporting in Feb 2022
Slide 12: Debt and Liquidity Metrics
Debt and Liquidity Metrics Net leverage ~1.2x Net debt defined as total debt outstanding ($452.8M) less cash ($65.9M). Leverage ratio (net) is defined as net debt divided by last twelve months adjusted EBITDA ($312.9M). Liquidity defined as the sum of cash balance and available revolving line of cre
Slide 13: Cash Flow Statement Highlights
Cash Flow Statement Highlights (1) 2020 includes benefits of payroll tax deferral (COVID-19 relief). Total payroll tax deferral of ~$55.4M (half due in December 2021 and half due in December 2022). Free cash flow defined as cash flow from operations less routine capital expenditures and required deb
Slide 14: Income Statement Adjustments
Income Statement Adjustments (1) The financial results for the three-month periods ended September 30, 2020, December 31, 2020, March 31, 2021, June 30, 2021 and September 30, 2021 are adjusted for certain items and should be considered a non-GAAP financial measure. A reconciliation of these non-GAA
Slide 15: 2021 Guidance
2021 Guidance
Slide 16: Amedisys 2021 Updated Guidance
Amedisys 2021 Updated Guidance Updated Revenue, EBITDA and EPS guidance ranges for FY 2021 reflect COVID impact and include Contessa and VNA acquisitions ($M except for EPS) AMED Core Performance Impact of Contessa and VNA Updated AMED Guidance Post Q2 Updated AMED Guidance Post Q3 Adjusted Revenue
Slide 17: Environmental, Social, Governance (E.S.G.) Considerations
Environmental, Social, Governance (E.S.G.) Considerations
Slide 18: Environmental, Social, Governance (E.S.G.) Considerations
Environmental, Social, Governance (E.S.G.) Considerations Sustainable, high-quality, patient focused, home-based care model Environmental, Social, Governance Environmental Amedisys is dedicated to the sustainability of our business and the communities in which we serve Environmental health has a str